Research programme: progesterone antagonists - Ligand/Wyeth
Alternative Names: LG 1127; LG 1447; Progesterone antagonists research programme - Ligand/Wyeth; WAY 160248; WAY-075Latest Information Update: 10 Aug 2009
At a glance
- Originator Ligand Pharmaceuticals; Wyeth
- Class
- Mechanism of Action Progesterone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer; Endometriosis; Female genital diseases; Pregnancy; Uterine leiomyoma
Most Recent Events
- 10 Aug 2009 Discontinued - Preclinical for Gynaecological disorders in USA (unspecified route)
- 10 Aug 2009 Discontinued - Preclinical for Pregnancy (Prevention) in USA (PO)
- 23 Jun 2004 This programme is still in active development - [(BIO 2004 Annual International Convention (BIO-2004)]